Te Ahumairangi Investment Management Ltd Has $1.93 Million Stock Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Te Ahumairangi Investment Management Ltd lessened its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 16.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 111,306 shares of the real estate investment trust’s stock after selling 21,314 shares during the quarter. Te Ahumairangi Investment Management Ltd’s holdings in Sabra Health Care REIT were worth $1,928,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of SBRA. Principal Financial Group Inc. boosted its stake in Sabra Health Care REIT by 2.5% in the fourth quarter. Principal Financial Group Inc. now owns 22,109,683 shares of the real estate investment trust’s stock valued at $382,940,000 after buying an additional 536,247 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Sabra Health Care REIT by 4.3% in the fourth quarter. JPMorgan Chase & Co. now owns 10,312,991 shares of the real estate investment trust’s stock worth $178,621,000 after acquiring an additional 426,074 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Sabra Health Care REIT by 1.4% in the 4th quarter. Geode Capital Management LLC now owns 6,381,525 shares of the real estate investment trust’s stock valued at $110,550,000 after purchasing an additional 86,727 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Sabra Health Care REIT by 13.0% in the 4th quarter. Bank of New York Mellon Corp now owns 4,039,651 shares of the real estate investment trust’s stock valued at $69,967,000 after purchasing an additional 463,601 shares in the last quarter. Finally, Wellington Management Group LLP grew its holdings in shares of Sabra Health Care REIT by 33.7% during the 4th quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust’s stock valued at $55,511,000 after purchasing an additional 808,207 shares during the last quarter. Institutional investors own 99.40% of the company’s stock.

Sabra Health Care REIT Trading Up 0.2 %

Shares of SBRA stock opened at $17.50 on Wednesday. Sabra Health Care REIT, Inc. has a 1-year low of $13.31 and a 1-year high of $20.03. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. The stock has a market cap of $4.16 billion, a price-to-earnings ratio of 33.02, a PEG ratio of 1.97 and a beta of 1.27. The stock has a 50-day moving average of $16.85 and a 200-day moving average of $17.66.

Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The firm had revenue of $182.35 million during the quarter, compared to analyst estimates of $178.01 million. On average, equities research analysts forecast that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were given a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 6.86%. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 226.42%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on SBRA shares. Mizuho reissued a “neutral” rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research report on Tuesday, January 7th. Finally, Truist Financial increased their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $19.33.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.